Clinical Trial Results:
A single center, randomized, partially blind, placebo
controlled, crossover, single oral dose study to assess the
effect of concomitant antacid (calcium carbonate) on the
pharmacokinetics and pharmacodynamics of SMC021 (0.8
mg salmon calcitonin/200 mg 5-CNAC) in healthy
postmenopausal women
Summary
|
|
EudraCT number |
2006-004177-95 |
Trial protocol |
DK |
Global completion date |
29 Nov 2006
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
06 Jan 2017
|
First version publication date |
06 Jan 2017
|
Other versions |
|
Summary report(s) |
CSMC021C2208 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.